SBI Rooms

SBI Rooms

Item Location Contact
Modulated DSC with refrigerated cooling
TA Instruments Q100 DSC
Bowne 4th floor Prof. Patrick Mather
Thermogravimetric Analysis
TA Instruments Q500
 Bowne 4th floor Prof. Patrick Mather
Rheometer
Anton Paar MCR501
Bowne 4th floor  Prof. Patrick Mather
Quartz Crystal Microbalance
SRS QCM200
 Bowne 4th floor Prof. Patrick Mather
Polarizing Microscope with optical microrheometer, heating/cooling stage, shear cell, spectrographic birefringence apparatus, and Mito CCD attachments
Olympus BX-51
Bowne 4th floor  Prof. Patrick Mather
Electrospinning apparatus
Custom Built
Bowne 4th floor Prof. Patrick Mather
Incubator Shakers
New Brunswick C24
Bowne 4th floor Prof. Patrick Mather
E-beam Evaporator (Ti, Au only)
Thermionics VE-100
 CST 3-036 Prof. Yan-Yeung Luk
Ellipsometer(discrete wavelength ellipsometer room) CST 4-041 Prof. Yan-Yeung Luk
Water Purification System
Millipore RiOs 5 and Milli-Q Biocel A-10
 CST 4-041 Prof. Yan-Yeung Luk
Polarizing Microscope
Olympus BX-51
CST 3-036 Prof. Yan-Yeung Luk
Potensiostat
Pine Model AFCBP1
 CST 3-036 Prof. Yan-Yeung Luk
Labconco purifier vertical clean bench
Laminar hood
CST 3-036 Prof. Yan-Yeung Luk
Cryogenic Storage System
VWR CryoPro BR-1
CST 3-036 Prof. Yan-Yeung Luk
Inverted Microscope
Motic AE-31
CST 3-036 Prof. Yan-Yeung Luk
Scanning Electron Microscope with X-ray Spectrophotometer
Joel 5600
Bowne 4th floor Prof. Patrick Mather
Atomic Force Microscope with Electrochemical Attachment and Nanoindentation Capabilityg Bowne 4th floor Prof. Jeremy Gilbert
Digital Instruments Nanoscope III  Bowne 4th floor Prof. Patrick Mather
Hydraulic testing apparatus with 8500-Plus panel control and computer-controlled custom data collection
Instron 1350
 Bowne 4th floor Prof. Patrick Mather
Fourier Transform Infrared Spectrometer with AutoImage FTIR Microscope
Perkin-Elmer Spectrum One
Bowne 4th floor Prof. Jeremy Gilbert
Differential scanning calorimeter
Perkin-Elmer Pyris 1
 Bowne 4th floor Prof. Patrick Mather
Inverted Fluorescence Microscope and Imaging System
Zeiss Axiovert 40 CFL with Phase Contrast
Bowne 4th floor Prof. Patrick Mather
Custom built indentation system for microindentation of soft, hydrated polymers and biological materials  Bowne 4th floor Prof. Jeremy Gilbert
Rotational Viscometer
Brookfield DV-E
 Bowne 4th floor Prof. Patrick Mather
MicroCT Scanner
Scanco 40
SUNY Upstate Prof. Kenneth Mann
Biaxial Servohydraulic Mechanical Test Frame
MTS Bionix
 SUNY Upstate Prof. Kenneth Mann
Fatigue crack growth measurement equipment
Fractomat/KrakGage
SUNY Upstate Prof. Kenneth Mann
Surface Profilometer
Mitutoyo 178-923
 SUNY Upstate Prof. Kenneth Mann
Viscometer with small sample adaptor
Brookfield
 SUNY Upstate Prof. Kenneth Mann
SUN and PC Workstations with FEA Modeling and Medical Imaging Software
PATRAN, MARC, NASTRAN and MIMICS
 SUNY Upstate Prof. Kenneth Mann
Digital Image Correlation System (2-D) with Spot RT Camera
RapidCorrelator
 SUNY Upstate Prof. Kenneth Mann
Florescence Microscope with Motorized Z-Drive and Deconvolution Software.
ZEISS AXIO IMAGER MOT M1
 445 Link Hall  Prof. Dacheng Ren
DNA and Protein Electrophoresis Systems  445 Link Hall  Prof. Dacheng Ren
Western Blot System  445 Link Hall  Prof. Dacheng Ren
Spectrophotometer
Gensys 5
 445 Link Hall  Prof. Dacheng Ren
Microplate reader
FLx800, Bio-Tek Instruments, Inc.
 445 Link Hall  Prof. Dacheng Ren
Microcentrifuge Machines
5415D & 5415R, Eppendorf
 445 Link Hall  Prof. Dacheng Ren
Micropulser Electroporator
FLx800, Bio-Tek Instruments, Inc.
 445 Link Hall  Prof. Dacheng Ren
Luminometer
20/20n, Turner Design
 445 Link Hall  Prof. Dacheng Ren
Biofilm Flow Chamber Systems  445 Link Hall  Prof. Dacheng Ren

David Marcus

David is currently a Managing Director of VIMAC Milestone Medica, LP, an early stage life science fund with VIMAC Ventures, LLC, a Boston based venture capital firm. The fund invests in the pharmaceutical, medical device and instrument sectors with start-up companies based on emerging technologies from leading academic institutions. At VIMAC, David participates in the formation and capitalization of companies, and working closely with the Fund’s portfolio companies, is involved in licensing transactions, collaborative research agreements and clinical trial activities.

Before joining VIMAC, David had over twenty-five years of business development and new venture experience including with Colgate-Palmolive in their corporate M&A group, as well as CFO of a Colgate subsidiary and Director of M&A, Industrial Products for Colgate’s billion dollar health care and industrial specialty subsidiary, The Kendall Company. At Kendall, David developed and implemented a strategic growth plan through acquisition, and later went on to start up and run an in-house industrial polymer membrane business, which he grew, spun off and successfully sold to a large multinational company. Most recently, before joining VIMAC, David was a General Partner with Wellfleet Investments in Boston, a private equity placement firm that developed a portfolio of emerging life science technologies from leading medical research institutions. While at Wellfleet, he also served as CEO of a medical clinic established by the firm based on an advanced gastrointestinal rehabilitation therapy developed at a Harvard teaching hospital.

David is a graduate of Syracuse University (’70, BA, Political Science) and is a member of the Board of Visitors for SU’s College of Arts and Sciences. He holds an MBA from Pace University. He lives in Newton, MA with his wife and two daughters.

David Marcus

David is currently a Managing Director of VIMAC Milestone Medica, LP, an early stage life science fund with VIMAC Ventures, LLC, a Boston based venture capital firm. The fund invests in the pharmaceutical, medical device and instrument sectors with start-up companies based on emerging technologies from leading academic institutions. At VIMAC, David participates in the formation and capitalization of companies, and working closely with the Fund’s portfolio companies, is involved in licensing transactions, collaborative research agreements and clinical trial activities.

Before joining VIMAC, David had over twenty-five years of business development and new venture experience including with Colgate-Palmolive in their corporate M&A group, as well as CFO of a Colgate subsidiary and Director of M&A, Industrial Products for Colgate’s billion dollar health care and industrial specialty subsidiary, The Kendall Company. At Kendall, David developed and implemented a strategic growth plan through acquisition, and later went on to start up and run an in-house industrial polymer membrane business, which he grew, spun off and successfully sold to a large multinational company. Most recently, before joining VIMAC, David was a General Partner with Wellfleet Investments in Boston, a private equity placement firm that developed a portfolio of emerging life science technologies from leading medical research institutions. While at Wellfleet, he also served as CEO of a medical clinic established by the firm based on an advanced gastrointestinal rehabilitation therapy developed at a Harvard teaching hospital.

David is a graduate of Syracuse University (’70, BA, Political Science) and is a member of the Board of Visitors for SU’s College of Arts and Sciences. He holds an MBA from Pace University. He lives in Newton, MA with his wife and two daughters.